The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehl, S
Right arrow Articles by Zinkernagel, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehl, S
Right arrow Articles by Zinkernagel, R
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene

The Journal of Immunology, Vol 156, Issue 7 2357-2360, Copyright © 1996 by American Association of Immunologists


CUTTING EDGE

Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo

S Ehl, U Hoffmann-Rohrer, S Nagata, H Hengartner and R Zinkernagel
Insitute of Experimental Immunology, Department of Pathology, University of Zurich, Switzerland.

To address the question of whether cytotoxic CD8+ T cells (CTL) activated in vivo are susceptible to cell death mediated by CD95 (Fas/Apo-1) ligand, a recombinant vaccinia virus expressing murine CD95L (vacc CD95L) was constructed, which drives CD95L expression to infected cells. T cells contacting virus-infected cells during priming, killing, or restimulation therefore encounter CD95L on the same cells. CD95L expression in vivo after infection with the vaccinia recombinant was sufficient to induce extensive necrosis in the liver of normal but not of CD95 mutant lpr mice. Fibroblast cell lines infected with this virus specifically killed CD95-transfected target cells and in vitro activated T cells. In contrast, when T cells were activated by a viral infection in vivo, they were not susceptible to CD95L-mediated cell death during the induction, effector, or memory phase in vitro or in vivo. These results suggest no direct role for CD95L in regulating CTL responses in vivo.


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. H. Kim, E. Y. Choi, and D. H. Chung
Donor Bone Marrow Type II (Non-V{alpha}14J{alpha}18 CD1d-Restricted) NKT Cells Suppress Graft-Versus-Host Disease by Producing IFN-{gamma} and IL-4
J. Immunol., November 15, 2007; 179(10): 6579 - 6587.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Onoe, H. Ohdan, D. Tokita, M. Shishida, Y. Tanaka, H. Hara, W. Zhou, K. Ishiyama, H. Mitsuta, K. Ide, et al.
Liver Sinusoidal Endothelial Cells Tolerize T Cells across MHC Barriers in Mice
J. Immunol., July 1, 2005; 175(1): 139 - 146.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Maeda, R. B. Levy, P. Reddy, C. Liu, S. G. Clouthier, T. Teshima, and J. L. M. Ferrara
Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease
Blood, March 1, 2005; 105(5): 2023 - 2027.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. C. McKarns and R. H. Schwartz
Distinct Effects of TGF-{beta}1 on CD4+ and CD8+ T Cell Survival, Division, and IL-2 Production: A Role for T Cell Intrinsic Smad3
J. Immunol., February 15, 2005; 174(4): 2071 - 2083.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C.-K. Min, Y. Maeda, K. Lowler, C. Liu, S. Clouthier, D. Lofthus, E. Weisiger, J. L. M. Ferrara, and P. Reddy
Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation
Blood, November 15, 2004; 104(10): 3393 - 3399.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. M. Davey, C. Kurts, J. F.A.P. Miller, P. Bouillet, A. Strasser, A. G. Brooks, F. R. Carbone, and W. R. Heath
Peripheral Deletion of Autoreactive CD8 T Cells by Cross Presentation of Self-Antigen Occurs by a Bcl-2-inhibitable Pathway Mediated by Bim
J. Exp. Med., October 7, 2002; 196(7): 947 - 955.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. S. Gregory, A. C. Repp, A. M. Holhbaum, R. R. Saff, A. Marshak-Rothstein, and B. R. Ksander
Membrane Fas Ligand Activates Innate Immunity and Terminates Ocular Immune Privilege
J. Immunol., September 1, 2002; 169(5): 2727 - 2735.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. H. Igney and P. H. Krammer
Immune escape of tumors: apoptosis resistance and tumor counterattack
J. Leukoc. Biol., June 1, 2002; 71(6): 907 - 920.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
H. Kim, K. A. Whartenby, R. W. Georgantas III, J. Wingard, and C. I. Civin
Human CD34+ Hematopoietic Stem/Progenitor Cells Express High Levels of FLIP and Are Resistant to Fas-Mediated Apoptosis
Stem Cells, March 1, 2002; 20(2): 174 - 182.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Parsons, R. G. Jones, M.-S. Tsao, B. Odermatt, P. S. Ohashi, and J. R. Woodgett
Expression of Active Protein Kinase B in T Cells Perturbs Both T and B Cell Homeostasis and Promotes Inflammation
J. Immunol., July 1, 2001; 167(1): 42 - 48.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Auphan-Anezin and A.-M. Schmitt-Verhulst
Differential Survival of Transferred CD8 T Cells and Host Reconstitution Depending on TCR Avidity for Host-Expressed Alloantigen
J. Immunol., June 15, 2001; 166(12): 7200 - 7207.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J.-H. Huang and M. L. Tykocinski
CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells
Int. Immunol., April 1, 2001; 13(4): 529 - 539.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-H. Wei, H. Yagita, M. G. Masucci, and V. Levitsky
Different Programs of Activation-Induced Cell Death Are Triggered in Mature Activated CTL by Immunogenic and Partially Agonistic Peptide Ligands
J. Immunol., January 15, 2001; 166(2): 989 - 995.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. Suzuki and P. J. Fink
The dual functions of Fas ligand in the regulation of peripheral CD8+ and CD4+ T cells
PNAS, February 15, 2000; 97(4): 1707 - 1712.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
P. Bertolino, M.-C. Trescol-Biemont, J. Thomas, B. F. de St Groth, M. Pihlgren, J. Marvel, and C. Rabourdin-Combe
Death by neglect as a deletional mechanism of peripheral tolerance
Int. Immunol., August 1, 1999; 11(8): 1225 - 1238.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Brochu, B. Rioux-Masse, J. Roy, D.-C. Roy, and C. Perreault
Massive Activation-Induced Cell Death of Alloreactive T Cells With Apoptosis of Bystander Postthymic T Cells Prevents Immune Reconstitution in Mice With Graft-Versus-Host Disease
Blood, July 15, 1999; 94(2): 390 - 400.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. B. Chappell, T. Z. Zaks, S. A. Rosenberg, and N. P. Restifo
Human Melanoma Cells Do Not Express Fas (Apo-1/CD95) Ligand
Cancer Res., January 1, 1999; 59(1): 59 - 62.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. Kurts, W. R. Heath, H. Kosaka, J. F.A.P. Miller, and F. R. Carbone
The Peripheral Deletion of Autoreactive CD8+ T Cells Induced by Cross-presentation of Self-antigens Involves Signaling through CD95 (Fas, Apo-1)
J. Exp. Med., July 20, 1998; 188(2): 415 - 420.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
I. Suzuki and P. J. Fink
Maximal Proliferation of Cytotoxic T Lymphocytes Requires Reverse Signaling through Fas Ligand
J. Exp. Med., January 5, 1998; 187(1): 123 - 128.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. J. Smyth and J. A. Trapani
The Relative Role of Lymphocyte Granule Exocytosis versus Death Receptor-Mediated Cytotoxicity in Viral Pathophysiology
J. Virol., January 1, 1998; 72(1): 1 - 9.
[Full Text] [PDF]


Home page
JEMHome page
R. P. Johnson
Upregulation of Fas Ligand by Simian Immunodeficiency Virus---A nef-arious Mechanism of Immune Evasion?
J. Exp. Med., July 7, 1997; 186(1): 1 - 5.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.